- Home
- AMTD vs DXR Comparison
AMTD vs DXR Comparison
Compare AMTD & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMTD | DXR |
|---|---|---|
| Founded | 2003 | 1970 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 59.0M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AMTD | DXR |
|---|---|---|
| Price | $0.83 | $9.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 11.2K | 2.2K |
| Earning Date | 04-29-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ $1.31 | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.71 | $8.56 |
| 52 Week High | $1.65 | $14.76 |
Technical Indicators
Market Signals| Indicator | AMTD | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 38.46 |
| Support Level | $0.71 | $9.64 |
| Resistance Level | $0.80 | $11.16 |
| Average True Range (ATR) | 0.04 | 0.25 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 29.95 | 8.30 |
Price Performance
Historical ComparisonAbout AMTD AMTD IDEA Group each representing six (6)
AMTD IDEA Group is a diversified institution and digital solutions conglomerate group, connecting companies and investors with world-wide markets. The group operates its businesses in five reportable and operating segments: capital market solutions segment, digital solutions and other services segment, media and entertainment segment, hotel operations, hospitality and VIP services segment, and strategic investment segment. The group generates the majority of its revenue from the strategic investment segment that engages in proprietary investments and management of world-wide investment portfolio (including listed and unlisted equity shares investments and movie rights investments). Its geographic areas are China, Europe, America, and Southeast Asia.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.